Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Ophthalmology: Sector Analysis

This vast unconsolidated sector offers huge opportunities particularly in the treatment of presbyopia and the growth of outsourcing. A panel of operators unpackage how they view the sector across EMEA and beyond. Confirmed speakers include: Dr Markus Hamm, OSG Johanna Öberg, Memira Eyecentre Paul Tomasic, Houlihan Lokey Ulla Napankangas, Coronaria Eye Health Chaired by: Tobias Koester, […]
September 20, 2021

Investing in Emerging Markets

Covid has had a huge impact, styming medical tourism and hitting profits hard. We hear how it has made investors rethink their approach and business models. What are the new opportunities that are now emerging? Confirmed speakers include: Charles Dalton, IFC Leandro Cuccioli, CDC Massimiliano Colella, Evercare Group Chaired by: Lee Murray, HBI
September 20, 2021

Investing in Health Care Property

Property investors have fled to health care over the pandemic and are now exploring opportunities far beyond “safe” North American and West European markets. How large are these opportunities and how far are West European countries developing into mature, secondary markets? Where, and how, is the immense public sector opening up to deals with investors? […]
September 20, 2021

Investing in Europe and the Middle East

What do investors think about key sectors and valuations in Europe and the Middle East? How has the pandemic changed their strategy? How will digital health change valuations and plans? Confirmed speakers include: Pascal Keutgens, CPPIB Martin Henrichs, UBS Phil Robinson, CVC Youssef Haidar, Nexus Gulf Chaired by: Max Hotopf, HBI
September 20, 2021

The post-Covid M&A landscape

Will pent-up investor demand force prices even higher in what most investors view as one of the safest sectors? What has happened to valuations and deal flow through the pandemic? Where are investors particularly focused today? Hedley Goldberg, Rothschild & Co
September 20, 2021

Domidep expands in Germany

Domidep, one of the top 10 for-profit care home operators in France by revenue, has expanded in the German market which it entered last year. It has acquired Römergarten Senioren-Residenzen GmbH (Römergarten) which comprises eight care homes providing a total of 660 beds.
September 16, 2021

Dutch lab consolidation to resume after COVID blip

The consolidation of The Netherlands' non-profit outpatient diagnostics sector by for-profit groups is expected to pick up in the coming months after a delay due to Covid, a partner at Deloitte tells HBI.
September 10, 2021

Nordic launches a process for €2bn+ Veonet

Strong rumours reported by HBI back in July that Nordic Capital-backed ophthalmology group Veonet (including Germany's largest operator by revenue Ober Scharrer) would come to market before the autumn have been proven correct. HBI understands the group has launched a process, and a price tag of in excess of €2bn is expected.
September 9, 2021

Air Liquide consolidates Polish med homecare

Global gas giant Air Liquide will buy Betamed, a Polish medicalised homecare provider, after the competition regulator approved the deal. It will now have over €50m of oxygen services in the country.
September 9, 2021

HCG sells Strand minority stake to Reliance

Indian oncology hospital group HealhCare Global Enterprises (HCG) has sold its minority stake in life sciences company Strand after buying in full its oncology lab and clinical trials business.
September 9, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us